Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.22.1
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 8,521 $ 8,274
Employee compensation and benefits 3,180 6,344
Professional fees 1,495 953
Facilities and other 53 53
Accrued expenses $ 13,249 $ 15,624